{"name":"Kyorin Pharmaceutical Co.,Ltd","slug":"kyorin-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPaEs2ekg4cGd3WUhxZkhEZ3A0Y3gtbkRJdl9vQ0dpYy02MkdwTlEtYVFSMndtNWMwaVFpZ1BObEJhTHAyUnlXUDd5a2FEWWJpbEpLekdzVlRFV2tXNHQ1YVhTckVhUTlxcnZtbmFlLVFwOFlVNllEX0ZfNFFKNTZ0VGRScGJxU2pxZmFLbUN5Q1M5aDRMMjU4LXUyUkVnLWt3aEFDY294YjVLVDVxUzdSa0gwb2VFWUF3bVk0LWN2X21oMXdhSmc?oc=5","date":"2026-03-25","type":"pipeline","source":"TipRanks","summary":"KYORIN Secures Exclusive Japan Rights to Promote and Distribute J&J’s SIRTURO - TipRanks","headline":"KYORIN Secures Exclusive Japan Rights to Promote and Distribute J&J’s SIRTURO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1kNThzU1RrU09sakFCdlJaOXVVZnZhcjg2OXpIajhaMEk4N25DaF95YXo0Tk9ZakdYRl92bnBLcXZmdkZJaG1YZzVCSFVmSFRmdHpybHhTMEdVQTJQZFNDb1dXYzExZw?oc=5","date":"2025-10-30","type":"pipeline","source":"MedPage Today","summary":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC - MedPage Today","headline":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE54X1ZIcGxIcVd1Yi12WG5BZHJBZU55N3hjWXRGbWV1VjVjQnp3NWw0X0hqQWN4LTVseHpvb0xpcXk1QnctS2FqcFlvU0lxUjhfU2VBWGhmSEhyeEcyd3Vfdk1zS2VWZ0dTc1E?oc=5","date":"2025-10-24","type":"pipeline","source":"Wiley Online Library","summary":"A Clinical Prediction Model for Early Colectomy in Patients With Severe Ulcerative Colitis Treated With Tacrolimus - Wiley Online Library","headline":"A Clinical Prediction Model for Early Colectomy in Patients With Severe Ulcerative Colitis Treated With Tacrolimus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxNYVZWMmxXaXRMNng3Um9YQXJNQ0lVSXlNeVdIblFmaTF1NEZMNGdzSFNtOUFrZWFqTE1DcC1PbXcwVF9MWk44OVVRUlBHc2lleG9XcWRMU0lVS0NXTmgwcWxQenVoYWhCcGlsZ2NDTHpCM3ZiVm1wdzZaZmdmbVVxZklSRUgwRWFUTXhMU3FfUWZQZndjcW9ncGFPamxoc3JxTUlJellCU2h2OHFibHV6VHJQTHpndUk4TkFlN0dTRjB5TDQ5RE1vNnlBd1lxVHdrVWVNY0RWeGlEU2dTN1kwNl9LNmVFTnV4dlF5ay1DQ0xubmlxUUdYVjl6RzRIR2x2RFFLM21Tcmt1TldNRlBEcnllZnA3Q0w3d2dOeUZTQXY2WWVpWDdNTGM3dmtfM2dtVDFEb1ZaSC1DbFJ2dHhRQldkdnMwMTVGTlhSSXNiZm5FckdXZHJV?oc=5","date":"2025-09-30","type":"deal","source":"GlobeNewswire","summary":"Hinge Bio Announces License and Collaboration with Kyorin - GlobeNewswire","headline":"Hinge Bio Announces License and Collaboration with Kyorin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1rUVdQczBmUnc5RUo3ZmVzZEtabmNId0xzazBMQ3k5TmFxUW5SSDlLNUNXcldaZGR0cGhpREJQNnAtUmlBUGk1REs2UlBCZmZ6MkdJcnRDVHJ2ZkpMQlZj?oc=5","date":"2025-09-10","type":"pipeline","source":"Nature","summary":"Vaginal Lactobacillus crispatus in early pregnancy associates with favorable gestational outcomes in a Japanese maternal-neonatal microbiome cohort - Nature","headline":"Vaginal Lactobacillus crispatus in early pregnancy associates with favorable gestational outcomes in a Japanese maternal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPc01MclV1dUFkSjZuWFJIQ2J0THF2bVdZTFBUQ185OEdvZjAyT1l4SUltZGtUYVhnNDlvbXFURDdkbzd0V3lBVTd0MzhpSjhiMjBpOFdTUml4S3EyeUh1d2JCc1FYZ3ZvaFVTWWNJTlJ2TUlydGZlZVpwbVRDcVNYRw?oc=5","date":"2025-05-21","type":"pipeline","source":"Yahoo Finance","summary":"aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential - Yahoo Finance","headline":"aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9LUEVFUy1NNzNKckNxaktFRURLdlBGaWdkbzYzMGlGcW5KU2xWdW1hX2p4bjMyRFRmTU41bk52NEl2LTlyMTF1UzlhazNjd3lkczlXeVE0RlYtdEJzWlJzY193?oc=5","date":"2025-04-10","type":"pipeline","source":"Pharmaceutical Executive","summary":"Pharma Pulse 4/10/25: Key Takeaways for AD Management, Coverage from LogiPharma Europe 2025 & more - Pharmaceutical Executive","headline":"Pharma Pulse 4/10/25: Key Takeaways for AD Management, Coverage from LogiPharma Europe 2025 & more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOU0lXenNlTWlZRXZ6R1JTTVhfSi1BWmNMaDR6RnpyT1RTTml2b2piTk54WmZPM0hlaVRpbENGVDhEd3V1ZG53ZTZsX1RIU094TFhxS2lfeXgweDA4MUJqbjVVWkduTVJyYkFNMUJRTTVMTkZVTzhfYmZibWFWdkdpZzRQblpRR3RQdE9tX1pR?oc=5","date":"2025-03-04","type":"pipeline","source":"The Pharma Letter","summary":"Kyorin offers Novartis timely new weapon in urticaria - The Pharma Letter","headline":"Kyorin offers Novartis timely new weapon in urticaria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQYXVtQWI5SDVoT2RQY2U1N29lZGlVNTVPei1fX18ydEV1MmNZOEM2M1ZzdmQ0SE9ySmVGY091UVZkaFZrajc5TGtqV1hyRHJBSHJLdDJPZGRVaTRzWnFIYWliUjh6NW41anVzSm5GVTlTNmhhX09namJxMk9YWWlDVHd2QUdEcWZrQVRZbnhMeFhpdGUwVHlzRHZfQVFyV0s0UFpvZlE3alVfTW84QlE?oc=5","date":"2025-03-03","type":"deal","source":"Fierce Biotech","summary":"Novartis hands over $55M upfront to license preclinical hives prospect from Japan's Kyorin - Fierce Biotech","headline":"Novartis hands over $55M upfront to license preclinical hives prospect from Japan's Kyorin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOQk1aRkdEcF96RTlDc0JINTVhMUc0czFDS2hscmtoU3ZKZ2o3UnotWkpxd1FOdHJWLXRBUWtfSzRfUXpJNHZCSVB3OFhiaUtOeWp1SGJFdENyVFVROTlJeXlhV1pqOW53Y3V5M25Sa3RsOEpyaVR6T21ROVFnOFlIT1lSb3lUSFBLN050OVVNSjViX3pfSnl2QmZlMldSbmJZX2NnWVV5Yw?oc=5","date":"2025-02-25","type":"deal","source":"BioWorld News","summary":"Kyorin drafts deals for chronic cough DTx, loss of smell therapy - BioWorld News","headline":"Kyorin drafts deals for chronic cough DTx, loss of smell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQa1NYZXJjbmpxWG5QTTE1Q2dJMk55NVhiQzNKZ25LQ2xVMmE5bWw2cEkzU2JUTFNoeWh4RWRrNzhuZ09UMk9NbnNxVjdtcmdZWUJSb0ZXUmxTb21VZ2dzNEZLNDNpWm5HemczazhRd2syZ0RGOUswOTBaN0tFSV9Da0lET0tVX2dUSlZwN0hvUmhwcEpCLVhUOFgzOTA4bi16VjE0YjVldW5nR19nY1NJdFliWUdvb2NkT1JLVFU4RkJYYktrM21JM3JBUXh2bXlOdXF5aTA0dE91TUpCVUJ6dmJzRmcyV2YwdG1tQ0NkMDRHb2IyMldfV3ZaMzVOWGFoMk03ODVORmFVaVJvZENXR1FR?oc=5","date":"2025-02-18","type":"pipeline","source":"prnewswire.com","summary":"KYORIN and Cyrano Therapeutics Enter into an Option Agreement for CYR-064 for the Treatment of Post-Viral Loss of Smell in Japan - prnewswire.com","headline":"KYORIN and Cyrano Therapeutics Enter into an Option Agreement for CYR-064 for the Treatment of Post-Viral Loss of Smell ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPdVlyTVdqYmRGQXFvR1ZmNDZMWVdYM1FYX1ltUzhxVXpoOThLcEdRTkFpejhPbEV1b3l0YTEta0ZDVjN3R0JzUkJ0d3BqcW9xajRzSWRQSVhpVUhkMUFYcFNFazBuQVdaQnVrejZLcms4VWtSWHVlU1NFZkh3bGc3Sm9qa0NzNkU5YnVUUG1HSFc?oc=5","date":"2022-08-03","type":"pipeline","source":"Citeline News & Insights","summary":"Kyorin Pharma To Shut Down US Subsidiary ActivX - Citeline News & Insights","headline":"Kyorin Pharma To Shut Down US Subsidiary ActivX - Citeline News & Insights","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}